ABOUT THIS PODCAST 🔗
Discoveries in technology, medicine, and nutrition are emerging with accelerating speed and improving our health and quality of life. Brought to you by Lonza, “A View On” podcast is a series of short conversations with industry leaders. Join us to discuss new trends that are impacting scientific research, drug discovery and business.
The series of monthly conversations with pharma, biotech and nutrition leaders from across industry and academia covers a wide range of topics from 3D bioprinting to therapeutic cannabinoids. In under ten minutes, each podcast takes the audience on a rapid but deep dive into an exciting development that promises to profoundly change or even revolutionize healthcare.
The series of monthly conversations with pharma, biotech and nutrition leaders from across industry and academia covers a wide range of topics from 3D bioprinting to therapeutic cannabinoids. In under ten minutes, each podcast takes the audience on a rapid but deep dive into an exciting development that promises to profoundly change or even revolutionize healthcare.
Hosts:
Update frequency:
every 73 days
Average audio length:
18 minutes
Guest interviews
Has sponsors
English
United States
46 episodes
since June 22, 2020
episodic
LATEST EPISODE 🔗
Season four of A View On has come to a close, and we are looking back at everything it covered.
This season took us across some of the most demanding frontiers in pharmaceutical manufacturing, in conversation with Lonza scientists, our partners, and voices from across the industry. Together they u…
PREVIOUS EPISODES 🔗
AI, Digitalization, and Advanced Synthesis in Pharma Manufacturing
In this episode, we speak with François Ricard, Christian Seufert, and Jan Vertommen from Lonza’s Advanced Synthesis platform about how AI-driven process innovation is shaping the development and manufacture of complex molecules.
…
Innovating Drug Development and Manufacturing: How External Collaborations Shape the Future of Biotherapeutics
In this episode of A View On, we speak with Andrew Brown, R&D Director at Lonza’s Integrated Biologics, and Zara Asgharpour, Director of External Innovation in Integrated Biologics, …
Process Analytical Technologies: Real-Time Insight for Smarter Manufacturing
In this episode, we speak with Carrie Mason, Thad Webster, and Ryan McDougall from Lonza’s PAT Center of Excellence about how Process Analytical Technologies are transforming the way biologics are developed and produced.
…
A View On Spray-Drying mRNA-based Products
Delivering mNRA Therapies: A Bullseye for Asthma and Future Pandemics
In this episode, we speak with Carsten Rudolph, CEO and co-founder of Ethris, about a novel spray-dried mRNA therapy designed to restore immune balance in asthma patients and prepare f…
Unlocking Microbial Manufacturing: Innovation Across the Pipeline
For more than 40 years, microbial fermentation has been the workhorse of biologic manufacturing. From the first recombinant insulin to today’s increasingly complex therapeutic formats, the technology has consistently adapted to mee…
A Swallow Instead of a Jab? A Capsule That Delivers Like an Injection
In this episode, we’re joined by Karsten Lindhardt, Founder and CEO of Biograil, to explore how a spring-loaded oral capsule could revolutionize drug delivery—offering patients a needle-free alternative with the same therapeuti…
Pain in the Gut: Next Generation Therapy for Acid Reflux in the Pipeline
In this episode, we are joined by Kjell Anderson, Chief Scientific Officer at Cinclus Pharma, to discuss a novel treatment for acid reflux.
Millions of people worldwide grapple with acid reflux, which may progress to gastroe…
Driving Innovation Through Collaboration: The Future of mRNA Therapies
In this episode, we are joined by three experts—Christoph Hein (Fraunhofer IPK), Bernhard Bobusch (FDX Fluid Dynamix), and Sönke Stocker (Lonza)—to explore how advanced fluidics, encapsulation techniques, and a truly collaborat…
Antibody-Based Therapies: Transforming Modern Medicine
In this episode, we are joined by Ronnie Wei, Head of Biologics Discovery and Development at ModeX Therapeutics, and Atul Mohindra, Head of R&D for Biologics at Lonza, to explore the development and manufacturing of monoclonal, bi-, and mu…
Disclaimer: The podcast and artwork embedded on this page are from Lonza, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PODCAST SEARCH ENGINE
You can use our website to search 3,836,670 podcasts and 197,713,917 episodes by people, places, or topics.
An investment in knowledge pays the best interest, so I listen to podcasts.
‐ Benjamin "Llamacorn" Franklin
PODCAST IS CLAIMED
This podcast page is claimed and managed by
@e4944
EDIT
Thank you for helping to keep the podcast database up to date.